101 related articles for article (PubMed ID: 23313585)
21. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.
Leombruni P; Fassino S; Lavagnino L; Orofino G; Morosini P; Picardi A
Psychother Psychosom; 2009; 78(4):254-7. PubMed ID: 19468260
[TBL] [Abstract][Full Text] [Related]
22. Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia.
Beyene KA; Gedif T; Gebre-Mariam T; Engidawork E
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1007-15. PubMed ID: 19650153
[TBL] [Abstract][Full Text] [Related]
23. A prospective study evaluating clinical outcomes and costs of three NNRTI-based HAART regimens in Kerala, India.
George C; Yesoda A; Jayakumar B; Lal L
J Clin Pharm Ther; 2009 Feb; 34(1):33-40. PubMed ID: 19125901
[TBL] [Abstract][Full Text] [Related]
24. A randomized comparison of two instruments for measuring self-reported antiretroviral adherence.
Mannheimer S; Thackeray L; Huppler Hullsiek K; Chesney M; Gardner EM; Wu AW; Telzak EE; Lawrence J; Baxter J; Friedland G;
AIDS Care; 2008 Feb; 20(2):161-9. PubMed ID: 18293124
[TBL] [Abstract][Full Text] [Related]
25. An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand.
Ruanjahn G; Roberts D; Monterosso L
AIDS Care; 2010 Dec; 22(12):1555-61. PubMed ID: 20582752
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic drug monitoring of antiretroviral therapy.
Rakhmanina NY; van den Anker JN; Soldin SJ
AIDS Patient Care STDS; 2004 Jan; 18(1):7-14. PubMed ID: 15006189
[TBL] [Abstract][Full Text] [Related]
27. Validation of a New Three-Item Self-Report Measure for Medication Adherence.
Wilson IB; Lee Y; Michaud J; Fowler FJ; Rogers WH
AIDS Behav; 2016 Nov; 20(11):2700-2708. PubMed ID: 27098408
[TBL] [Abstract][Full Text] [Related]
28. HIV-infected patients' adherence to highly active antiretroviral therapy: a phenomenological study.
Mohammadpour A; Yekta ZP; Nikbakht Nasrabadi AR
Nurs Health Sci; 2010 Dec; 12(4):464-9. PubMed ID: 21210925
[TBL] [Abstract][Full Text] [Related]
29. Assessing baseline religious practices and beliefs to predict adherence to highly active antiretroviral therapy among HIV-infected persons.
Vyas KJ; Limneos J; Qin H; Mathews WC
AIDS Care; 2014; 26(8):983-7. PubMed ID: 24499276
[TBL] [Abstract][Full Text] [Related]
30. Patient readiness to adhere to HAART.
Grimes RM; Grimes DE
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(6):364-6. PubMed ID: 19952288
[TBL] [Abstract][Full Text] [Related]
31. Clinical benefit of interventions driven by therapeutic drug monitoring.
Rendón A; Núñez M; Jiménez-Nácher I; González de Requena D; González-Lahoz J; Soriano V
HIV Med; 2005 Sep; 6(5):360-5. PubMed ID: 16156885
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of saliva as an alternative matrix for monitoring plasma Zidovudine, Lamivudine and nevirapine concentrations in Rwanda.
Gras A; Schneider S; Karasi JC; Ternes AM; Sauvageot N; Karasi-Omes C; Henry AP; Schmit JC; Seguin-Devaux C; Arendt V
Curr HIV Res; 2011 Jun; 9(4):223-8. PubMed ID: 21671885
[TBL] [Abstract][Full Text] [Related]
33. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.
Grierson J; Koelmeyer RL; Smith A; Pitts M
HIV Med; 2011 Oct; 12(9):562-9. PubMed ID: 21554524
[TBL] [Abstract][Full Text] [Related]
34. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms.
Webb MS; Vanable PA; Carey MP; Blair DC
AIDS Educ Prev; 2009 Jun; 21(3 Suppl):94-105. PubMed ID: 19537957
[TBL] [Abstract][Full Text] [Related]
35. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder.
Applebaum AJ; Richardson MA; Brady SM; Brief DJ; Keane TM
AIDS Behav; 2009 Feb; 13(1):60-5. PubMed ID: 18690532
[TBL] [Abstract][Full Text] [Related]
36. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
[TBL] [Abstract][Full Text] [Related]
37. The link between religion and HAART adherence in pediatric HIV patients.
Park J; Nachman S
AIDS Care; 2010 May; 22(5):556-61. PubMed ID: 20397076
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.
Notari S; Bocedi A; Ippolito G; Narciso P; Pucillo LP; Tossini G; Donnorso RP; Gasparrini F; Ascenzi P
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):258-66. PubMed ID: 16406832
[TBL] [Abstract][Full Text] [Related]
39. Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal.
Laurent C; Tchatchueng Mbougua JB; Ngom Guèye NF; Etard JF; Diouf A; Landman R; Molinari N; Girard PM; Sow PS; Ndoye I; Delaporte E;
Trop Med Int Health; 2011 Feb; 16(2):217-22. PubMed ID: 21087377
[TBL] [Abstract][Full Text] [Related]
40. How late is too late? Timeliness to scheduled visits as an antiretroviral therapy adherence measure in Nairobi, Kenya and Lusaka, Zambia.
Blacher RJ; Muiruri P; Njobvu L; Mutsotso W; Potter D; Ong'ech J; Mwai P; Degroot A; Zulu I; Bolu O; Stringer J; Kiarie J; Weidle PJ
AIDS Care; 2010 Nov; 22(11):1323-31. PubMed ID: 20711886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
